Exelixis Inc (EXEL.O)

EXEL.O on Nasdaq

3.45USD
12:42pm EDT
Change (% chg)

$-0.06 (-1.71%)
Prev Close
$3.51
Open
$3.55
Day's High
$3.55
Day's Low
$3.37
Volume
763,610
Avg. Vol
3,333,231
52-wk High
$4.55
52-wk Low
$1.26

EXEL.O

Chart for EXEL.O

About

Exelixis Inc. is a biopharmaceutical company. The Company is engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing on resources development and commercialization of COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC) in the United... (more)

Overall

Beta: 2.81
Market Cap(Mil.): $687.69
Shares Outstanding(Mil.): 195.92
Dividend: --
Yield (%): --

Financials

  EXEL.O Industry Sector
P/E (TTM): -- 427.80 39.20
EPS (TTM): -1.17 -- --
ROI: -70.41 -4.40 16.19
ROE: -- -5.34 17.33
Search Stocks

Competitors

  Price Chg
AstraZeneca plc (AZN.L) 4,178.00p +29.00
Pfizer Inc. (PFE.N) $33.49 +0.24
ArQule, Inc. (ARQL.OQ) $1.60 -0.03
GlaxoSmithKline plc (GSK.L) 1,338.50p -3.50
Algeta ASA (ALGETA.OL) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks